<DOC>
	<DOCNO>NCT02941458</DOCNO>
	<brief_summary>The GECP , commitment improve treatment prognosis patient lung cancer thoracic tumor , mark individualization treatment accord expression marker predictive response chemotherapeutic agent molecular inhibitor cell proliferation one primary objective . This could significantly improve prognosis patient lung cancer , lead radical change routine clinical practice . The aim register explore data available patient treat thoracic tumour .</brief_summary>
	<brief_title>Thoracic Tumours Register</brief_title>
	<detailed_description>In Europe , patient lung cancer poor prognosis , limited improvement 1999 2007 . Potential advantage centralization care discussion treatment strategy multidisciplinary team , suggest studies,13 require research . However , priority prevent lung cancer implement anti-smoking policy control asbestos exposure throughout Europe , recommend World Health Organization ( WHO ) 2008.14 Other priority reduce level residential radon risk area , early diagnosis improve result surgery , still main curative treatment . The variability diagnostic process , treatment advocacy , well anticipated increase associate mortality Spain coming year , stimulate creation epidemiological , observational , multicenter study case lung cancer thoracic tumor diagnose treated medical personnel , include thoracic surgeon medical oncologist . Data study collect retrospectively prospectively , enable extensive study epidemiological therapeutic factor related disease .</detailed_description>
	<mesh_term>Thoracic Neoplasms</mesh_term>
	<criteria>Patients thoracic disease , treat active treatment treat ( palliative care ) Patients type tumour</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>